Another recent study showed that APOE ε4 carriers have accelerated breakdown of the blood-brain barrier (BBB) in the hippocampus and medial temporal lobe contributing to cognitive decline independent of Alzheimer’s disease pathology [47]. This evidence concerns the gene APOE and Alzheimer disease.